Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence

Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence Collaboration Aims to Increase Equitable Trial Access and Patient Retention
BURLINGTON, N.C. Labcorp (NYSE: LH), a leading global life sciences company, and ConcertAI , LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) and real-world data (RWD) solutions for life science companies and health care providers, today announced a collaboration to optimize precision oncology research. The companies will work together to launch clinical studies in ways that minimize the burden on physician practices, drive faster patient recruitment, maximize patient retention and ensure equitable access to research as …

Read the source article at Overview
2021-12-01 14:21:00